Sleep Disorder
Sleep disturbances occur in about 12% to 25% of the general population and are often associated with situational stress, illness, aging, and drug treatment. Poor sleep adversely affects daytime mood and performance. In the general population, persistent insomnia has been associated with a higher risk of developing clinical anxiety or depression. Sleep disturbances and, ultimately, sleep-wake cycle reversals, can be early signs of a developing delirium.
Four major categories of sleep disorders have been defined by the Sleep Disorders Classification Committee:
- Disorders of initiating and maintaining sleep (insomnias)
- Disorders of the sleep-wake cycle
- Dysfunctions associated with sleep; sleep stages, or partial arousals (parasomnias)
- Disorders of excessive somnolence
Risk factors for sleep disorders:
- Disease factors including paraneoplastic syndromes with increased steroid production; symptoms associated with tumor invasion (e.g., obstruction, pain, fever, shortness of breath, pruritus, fatigue)
- Treatment factors including symptoms related to surgery (e.g., pain, frequent monitoring, narcotics); chemotherapy (e.g., exogenous corticosteroids); symptoms related to chemotherapy
- Medications such as narcotics, sedatives/hypnotics, steroids, caffeine/nicotine, some antidepressants, dietary supplements including some vitamins, diet pills and other products promoting weight loss and appetite.
